Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation

Molecular deletion of transglutaminase 2 (TG2) has been shown to improve function and survival in a host of neurological conditions including stroke, Huntington's disease, and Parkinson's disease. However, unifying schemes by which these cross-linking or polyaminating enzymes participate b...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Sleiman, Sama F. (author)
مؤلفون آخرون: Basso, Manuela (author), Xia, Li (author), Berlin, Jill (author), Ko, Brendan (author), Haskew-Layton, Renee (author), Kim, Eunhee (author), Antonyak, Marc A. (author), Cerione, Richard A. (author), Lismaa, Siri E. (author), Willis, Dianna (author), Cho, Sunghee (author), Ratan, Rajiv R. (author)
التنسيق: article
منشور في: 2012
الوصول للمادة أونلاين:http://hdl.handle.net/10725/6138
https://doi.org/10.1523/JNEUROSCI.3353-11.2012
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.jneurosci.org/content/32/19/6561.short
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!